Investing Legend Hints the End May Be Near for These 3 Iconic Stocks
Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
Shares Stats
| Shares Outstanding | 93,740,000 |
| Shares Float | 88,380,000 |
| Shares Short | 8,800,000 |
| Insider Holdings | 320% |
| Institution Holdings | 99.43% |
About Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for the treatment of long-chain fatty acid oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidates that are in Phase 3 clinical trials include UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta; UX111, an AAV9 gene therapy product candidate for the treatment of patients with Sanfilippo syndrome type A, or MPS IIIA, a rare lysosomal storage disease; DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; and GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome. It also develops UX701 that is in Phase 2 clinical trial for the treatment of Wilson disease; and UX053 for the treatment of glycogen storage disease type III. Ultragenyx Pharmaceutical Inc. has collaboration and license agreement with Kyowa Kirin Co., Ltd.; Saint Louis University; Baylor Research Institute; REGENXBIO Inc.; GeneTx; Mereo; University of Pennsylvania; Solid Biosciences Inc.; Regeneron; Abeona; and Arcturus Therapeutics Holdings Inc. The company was incorporated in 2010 and is headquartered in Novato, California.
General
| Name | Ultragenyx Pharmaceutical Inc |
| Ticker | RARE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 1,294 |
Highlights
| Analyst Target | 84.60 |
| Market Cap | 2,582,900,000 |
| PEG Ratio | -0.24 |
| EBITDA | -477,876,992 |
Financials
| Curr Year EPS Estimate | -5.32 |
| Next Quarter EPS Estimate | -1.39 |
| Profit Margin | -93.04% |
| Operating Margin | -86.94 |
| Return on Assets | -0.25 |
| Return on Equity | -3.77 |
| Revenue | 590.7M |
| Earnings Per Share | -5.83 |
| Revenue Per Share | 6.32 |
| Gross Profit | -182,318,000 |
| Quarterly Revenue Growth | 0.28 |
Valuation
| Price/Sales (Trailing 12 Mt.) | 4.37 |
| Price/Book (Most Recent Quarter) | 17.79 |
Earnings
Trump Says 5 Jets Downed During India-Pakistan Conflict: '...Shot Out Of The Air'
President Donald Trump during a dinner with Republican lawmakers stated, that up to 5 jets were shot down during the India-Pakistan conflict.
Colonel Sanders Sold KFC For $2 Million Only To See The New Owners Cash Out For $285 Million Few Years Later — Why He Then Sued Them
Harland Sanders built Kentucky Fried Chicken into a success but sold it for just $2M, feeling sidelined as it grew into a global brand. He died in 1980.
Is Elon's Empire Crumbling? - Ad
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.
Rigetti Computing, Netflix, Johnson & Johnson, United Airlines And ASML: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks moved higher today, with the Dow Jones gaining more than 200 points, or 0.5%, to close at 44,254.78.
Draganfly Stock Is Moving Higher Wednesday: What's Going On?
Dragonfly shares are trading higher Wednesday after the company announced its Cammander3 XL UAV has been selected by the Department of Defense for advanced operation initiatives.
If You Missed Tesla, Here's Your "Second Chance"... - Ad
If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.
Mark Cuban Praised His 'Hustling' Son, But Told Kids: 'Figure Out Who You Are, You Don't Need To Follow In My Footsteps'
Jake Cuban embarked on an entrepreneurial journey reminiscent of his father's early business ventures by starting a side hustle selling candy at his school.
Drone attacks on oil fields in Iraq's Kurdish region shut down another facility
BAGHDAD (AP) — Drones targeted Wednesday, the latest in a series of attacks in recent days that have put several oil facilities out of commission.
Palantir Makes a Move - Now Look At the Chart - Ad
One under-the-radar company just partnered with Palantir to take autonomous security to the next level.
Is Costco Stock Topping Out? Key Price Levels To Watch
Costco stock (COST) may have formed a long-term peak. Adhishthana Principles suggest the next move could define the stock's future trajectory.
Barbara Corcoran, Who Sold Her Real Estate Empire For $66 Million Decades Ago, Says This Is The 'Most Under-Utilized' Tool In The Workplace
Real estate millionaire Barbara Corcoran built a $20 billion brokerage by making work fun with picnics, rewards, and perks, not strict rules.
Tap Into the $65B 'Shroom Boom' - Ad
People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.
Inside the high-stakes battle to win a New York City casino license
NEW YORK (AP) — A Caesars Palace casino in the heart of Times Square. A sprawling gambling hall along Coney Island’s iconic boardwalk. A Hard Rock casino complex next to the home stadium of baseball’s New York Mets.
The Last Time This Warning Flashed, S&P 500 Crashed The Most Since 2008
A rare warning signal has reappeared in the market, with a low bull-bear spread and high investor indecision.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Philly cheesesteak maker challenged by the ever-rising cost of beef
PHILADELPHIA (AP) — Ken Silver knows beef because he knows Philly cheesesteak. He hopes that a summer spike in how much he pays for his restaurant's main product doesn't cause heartburn for him or his customers.
Trump Diagnosed With Chronic Venous Insufficiency, A Common Circulatory Condition In Over-70s, White House Says He's 'In Excellent Health'
The White House revealed President Trump is diagnosed with chronic health condition.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Japanese leader Ishiba vows to remain despite speculation, says he will focus on new US trade deal
TOKYO (AP) — Prime Minister on Wednesday vowed to remain in power to oversee the implementation of a , despite media speculation and growing calls for him to resign after a .
Tesla Stock Falls Over 6% Pre-Market After Q2 Miss — Elon Musk Warns Of 'Rough Few Quarters' Ahead
Tesla stock falls more than 6% pre-market after Q2 earnings call. Sales decline, EV incentives end, and new Model Y trim disappoints.
Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad
Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.
Pilot arrested on child sex abuse material charges after landing at San Francisco airport
SAN FRANCISCO (AP) — A pilot was arrested aboard a Delta Air Lines flight and federal agents took him into custody from the cockpit after the plane landed at San Francisco International Airport.
Retirees, here’s how to tweak the 4% rule to protect your nest egg
New retirees might enter a different environment than their predecessors—the economy or market might have changed slightly or dramatically.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Trump Says Coca Cola Has Agreed To Use Real Cane Sugar In Their US Sodas: 'It's Just Better'
Trump says he's convinced Coca-Cola to use real cane sugar in its U.S. products after discussing with them. It comes amid health concerns of chemicals in products.
Mark Zuckerberg's Meta And Elon Musk's X Fight Back Against Efforts By Italy To Tax Free Access To Social Media In Exchange For Users' Personal Data
Italy's unprecedented VAT lawsuit against Meta, X and LinkedIn over the exchange of user data for free access could set a major precedent for how digital services are taxed across the EU.
Palantir's AI Is Going Physical - Ad
The next wave of security AI is happening now. Palantir just joined forces with a company already doing the work.
Cathie Wood Pounces On Tesla Dip: Ark Snaps Up $43.7 Million In EV Stock While Ditching Crypto Shares Amid Bitcoin Frenzy
On Thursday, Cathie Wood-led Ark Invest made significant trades, prominently featuring the purchase of Tesla Inc. (NASDAQ:TSLA) shares across multiple ETFs.
Martin Luther King Jr. FBI Records Released By Trump Administration: Al Sharpton Says, 'Desperate Attempt' To Distract People From Epstein Firestorm
Trump administration released over 240,000 pages of FBI surveillance records on Martin Luther King Jr., sparking controversy among his family and civil rights organizations.
Investing Legend Hints the End May Be Near for These 3 Iconic Stocks - Ad
Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
Gene Munster Says AI Risk Is 'Still On The Table' For Google Despite Blowout Q2 Earnings, But Admits Search Was 'Strong' For Alphabet: 'Investors Will Likely Come Back'
Gene Munster praised Google Search as "rock solid" following Alphabet's blowout Q2 earnings, but cautioned that AI disruption still poses a long-term risk to the company's future dominance.
Australian prime minister indulges in panda diplomacy as state visit in China nears end.
BEIJING (AP) — Australian Prime Minister Anthony Albanese has toured a panda breeding facility in the final stages of an extended state visit that has cast China as a fellow champion of a global fair trade system .
Is Elon's Empire Crumbling? - Ad
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.
US Dollar Can Lose Its 'Supremacy Premium' If Fed Interferes With Bond Market: Currencies Are 'Release Valve For Unsustainable Fiscal Policy'
The U.S. dollar's status as the premier currency could be at risk if the Federal Reserve intervenes in the bond markets.
Elon Musk's xAI Plans To Raise $12 Billion In Debt To Buy Nvidia Chips And Build One Of The World's Largest AI Superclusters: Report
Elon Musk's xAI is reportedly seeking $12 billion in debt financing to buy Nvidia chips and build a massive AI supercluster, signaling an aggressive push to stay competitive in the global AI arms race.
If You Missed Tesla, Here's Your "Second Chance"... - Ad
If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.
Nvidia Is 'On A March To $5 Trillion' Market Capitalization, Says Dan Ives As He Predicts Bullish Environment For Tech And Crypto: 'Very Strong Second Half'
Wedbush analyst Daniel Ives delivered an optimistic outlook for Nvidia Corp. (NASDAQ:NVDA) and the broader tech and crypto markets, predicting a $5 trillion market capitalization for the tech giant led by Jensen Huang.
Bitcoin Consolidates Amid Trump's Tariff Moves; Ethereum, Dogecoin Fall: Analyst Foresees 'Violent' ETH Rally Once It Breaks This Level
Leading cryptocurrencies diverged from stocks on Wednesday as investors parsed tariff-related developments ahead of the Aug. 1 deadline.
Palantir Makes a Move - Now Look At the Chart - Ad
One under-the-radar company just partnered with Palantir to take autonomous security to the next level.
Satya Nadella Touts Copilot Mode In Edge, Can Microsoft Finally Leverage AI To Snag Browser Dominance From Google Chrome?
Microsoft has launched an experimental Copilot Mode in its Edge browser, with CEO Satya Nadella highlighting multi-tab AI as a key step toward reinventing web browsing with generative AI.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.